Your browser doesn't support javascript.
loading
Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF.
Zhuang, Xibin; Zhao, Chao; Li, Jiayu; Su, Chunxia; Chen, Xiaoxia; Ren, Shengxiang; Li, Xuefei; Zhou, Caicun.
Afiliação
  • Zhuang X; Department of Respiratory Medicine, Quanzhou First Hospital, Quanzhou, China.
  • Zhao C; Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
  • Li J; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
  • Su C; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
  • Chen X; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
  • Ren S; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
  • Li X; Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
  • Zhou C; Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Cancer Med ; 8(6): 2858-2866, 2019 06.
Article em En | MEDLINE | ID: mdl-31016879
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Mutação Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Mutação Idioma: En Ano de publicação: 2019 Tipo de documento: Article